ArticleFrontiers in aging neuroscience2010

The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease.

Nektaria Nicolakakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.